TENAX CFO files Form 3 with zero share holdings

TENAX THERAPEUTICS, INC. filed an initial ownership report for Chief Financial Officer Thomas R. Staab II on Form 3.

Rhea-AI Filing Summary

TENAX THERAPEUTICS, INC. filed an initial ownership report for Chief Financial Officer Thomas R. Staab II on Form 3. The filing lists his position in the company’s Common Stock as zero shares owned directly following the reported date, establishing a baseline of reported insider holdings.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider STAAB THOMAS R II

Role Chief Financial Officer

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 0 shares (Direct)

Key Figures

Common Stock held after date: 0.0000 shares Holding entries: 1 entry Unknown transaction code entries: 1 entry

3 metrics

Common Stock held after date 0.0000 shares Total shares of Common Stock owned directly following transaction date

Holding entries 1 entry Number of holding-type records in this Form 3

Unknown transaction code entries 1 entry Transactions classified with unknown code in transaction summary

Key Terms

Form 3, Common Stock, beneficial ownership

3 terms

Form 3 regulatory

"filed an initial ownership report for Chief Financial Officer Thomas R. Staab II on Form 3"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Common Stock financial

"The filing lists his position in the company’s Common Stock as zero shares"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

beneficial ownership regulatory

"The filing records his initial beneficial ownership position in the company’s Common Stock"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the TENX Form 3 filing for Thomas R. Staab II show?

The Form 3 shows that Chief Financial Officer Thomas R. Staab II reported initial ownership of 0 shares of TENAX THERAPEUTICS Common Stock. This establishes his baseline reported holdings as of the filing’s reported date for future comparison with later insider filings.

Who is the reporting person in the TENX Form 3 filing?

The reporting person is Thomas R. Staab II, the Chief Financial Officer of TENAX THERAPEUTICS, INC. The filing records his initial beneficial ownership position in the company’s Common Stock for U.S. securities law reporting purposes.

How many TENAX THERAPEUTICS (TENX) shares does the CFO report owning?

The filing states that the Chief Financial Officer has 0.0000 shares of TENAX THERAPEUTICS Common Stock owned directly following the reported date. This means no Common Stock position is reported on this initial ownership statement.

Does the TENX Form 3 show any insider buying or selling activity?

No insider buying or selling is indicated. The transaction is classified as a holding entry with an unknown transaction code and zero shares reported. It simply records that total Common Stock held directly after the reported date is 0.0000 shares.

What type of security is covered in the TENX Form 3 for the CFO?

The Form 3 covers Common Stock of TENAX THERAPEUTICS, INC. It reports the number of shares owned following the reported date, which in this case is 0.0000 shares held directly by the Chief Financial Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/13/2026 - 04:56 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

STAAB THOMAS R II

(Last) (First) (Middle)

101 GLEN LENNOX DRIVE SUITE 300

(Street)

CHAPEL HILL NORTH CAROLINA 27517

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
05/11/2026

3. Issuer Name and Ticker or Trading Symbol
TENAX THERAPEUTICS, INC. [ TENX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ S. Halle Vakani, as Attorney-in-Fact	05/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)